Biblio

135 resultats trouvés
Filtres: Auteur is Wendling, D.  [Clear All Filters]
S
Frederic M., Delphine W.V, Prati C., Wendling D., Verhoeven F..  2021.  SAFETY OF BIOLOGIC TREATMENTS IN SOLID ORGAN TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 80:719.
Verhoeven F., Weil-Verhoeven D., Thevenot T., Prati C., Di Martino V., Wendling D..  2018.  SAFETY OF TNF BLOCKERS IN CASE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND CIRRHOSISA SYSTEMATIC REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 77:1381-1382.
Romand X., Paclet M.H, Courtier A., Nguyen M.-V-C, Berenbaum F., Wendling D., Gaudin P., Baillet A..  2018.  SERUM CALPROTECTIN IS CORRELATED WITH DISEASE ACTIVITY IN EARLY AXIAL SPONDYLOARTHRITIS BUT DOES NOT PREDICT RADIOGRAPHIC PROGRESSION AT 2 YEARS: RESULTS FROM THE DESIR COHORT. ANNALS OF THE RHEUMATIC DISEASES. 77:357-358.
Wendling D., Vidon C., Khan K.A, Guillot X., Godfrin-Valnet M., Abbas W., Toussirot E., Baud L., Prati C., Herbein G..  2014.  SIRT-1 ACTIVITY IN PBMC FROM PATIENTS WITH RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 73:842.
Wendling D., Delattre E., Abbas W., Guillot X., Godfrin-Valnet M., Khan K.A, Toussirot E., Baud L., Prati C., Herbein G..  2014.  SIRT-1 ACTIVITY IN PBMC FROM PATIENTS WITH SPONDYLOARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 73:804.
Wendling D., Delattre E., Abbas W., Guillot X., Godfrin-Valnet M., Khan K.A, Toussirot E., Baud L., Prati C., Herbein G..  2014.  SIRT-1 ACTIVITY IN PBMC FROM PATIENTS WITH SPONDYLOARTHRITIS - PRELIMINARY RESULT. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 32:778.
Wendling D., Delattre E., Abbas W., Guillot X., Godfrin-Valnet M., Khan K.A, Toussirot E., Baud L., Prati C., Herbein G..  2014.  SIRT-1 ACTIVITY IN PBMC FROM PATIENTS WITH SPONDYLOARTHRITIS - PRELIMINARY RESULT. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 32:778.
Prati C., Demougeot C., Guillot X., Verhoeven F., Wendling D..  2016.  SUBCLINICAL ATHEROSCLEROSIS IN ANKYLOSING SPONDYLITIS - DOES IT REALLY EXIST AND WHICH ARE THE EFFECTS OF TREATMENTS? A SYSTEMATIC REVIEW CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 34:751.
Prati C., Guillot X., Verhoeven F., Demougeot C., Wendling D..  2016.  SUBCLINICAL ATHEROSCLEROSIS IN ANKYLOSING SPONDYLITIS. DOES IT REALLY EXIST AND WHICH ARE THE EFFECTS OF TREATMENTS? A SYSTEMATIC REVIEW ANNALS OF THE RHEUMATIC DISEASES. 75:583-584.
Prati C., Demougeot C., Guillot X., Verhoeven F., Wendling D..  2016.  SUBCLINICAL ATHEROSCLEROSIS IN ANKYLOSING SPONDYLITIS - DOES IT REALLY EXIST AND WHICH ARE THE EFFECTS OF TREATMENTS? A SYSTEMATIC REVIEW CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 34:751.
T
Morel J., Berthelot J.M, Constantin A., Debandt M., Gaudin P., Vittecoq O., Maillefert J.F, Meyers O., Pham T., Saraux A. et al..  2014.  THE FLARE-RA (FLARE IN RHEUMATOID ARTHRITIS) QUESTIONNAIRE IS ABLE TO DETECT DISEASE ACTIVITY INCREASE, IE, FLARE, OCCURRING BETWEEN 2 VISITS TO THE RHEUMATOLOGIST. ANNALS OF THE RHEUMATIC DISEASES. 73:647.
Charpentier A., Verhoeven F., Sondag M., Guillot X., Prati C., Wendling D..  2017.  THERAPEUTIC RESPONSE TO PREDNISONE ACCORDING TO THE AGE IN POLYMYALGIA RHEUMATICA: A CONTROLLED STUDY. ANNALS OF THE RHEUMATIC DISEASES. 76:417-418.
Hecquet S., Totoson P., Martin H., Peyronnel C., Tournier M., Saas P., Pais-De-Barros J.P, Wendling D., Demougeot C., Verhoeven F..  2021.  TIME COURSE OF INTESTINAL PERMEABILITY AND BACTERIAL TRANSLOCATION IN THE MODEL OF ADJUVANT-INDUCED ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 80:1062.
Totoson P., Maguin-Gate K., Nappey M., Wendling D., Demougeot C..  2014.  Time-course and mechanisms of macrovascular endothelial dysfunction in rheumatoid arthritis: a study in rats. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 28:30.
Totoson P., Maguin-Gate K., Nappey M., Wendling D., Demougeot C..  2014.  Time-course and mechanisms of macrovascular endothelial dysfunction in rheumatoid arthritis: a study in rats. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 28:30.
Totoson P., Maguin-Gate K., Nappey M., Wendling D., Demougeot C..  2014.  Time-course and mechanisms of macrovascular endothelial dysfunction in rheumatoid arthritis: a study in rats. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 28:30.
Totoson P., Maguin-Gate K., Nappey M., Prati C., Wendling D., Demougeot C..  2014.  TIME-COURSE OF MICROVASCULAR VERSUS MACROVASCULAR ENDOTHELIAL DYSFUNCTION IN RAT ADJUVANT-INDUCED ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 73:849.
Totoson P., Prati C., Wendling D., Quirie A., Marie C., Demougeot C..  2020.  TOFACITINIB REVERSED ENDOTHELIAL DYSFUNCTION IN RHEUMATOID ARTHRITIS: MECHANISTIC INSIGHTS FROM THE RAT ADJUVANT-INDUCED ARTHRITIS MODEL. ANNALS OF THE RHEUMATIC DISEASES. 79:250.
Giraud N., Sondag M., Chouk M., Verhoeven F., Wendling D., Prati C..  2021.  TOPOGRAPHY OF 18F-FDG PET/CT INFLAMMATORY SITES IN SPONDYLOARTHRITIS IN COMPARISON TO POLYMYALGIA RHEUMATICA AND TO PATIENTS WITHOUT INFLAMMATORY RHEUMATIC DISEASE. ANNALS OF THE RHEUMATIC DISEASES. 80:1279-1280.
Assaraf M., Chevet B., Philippe P., Avouac J., Delacour M., Houvenagel E., Pascart T., Henry J., Roux C., Wendling D. et al..  2021.  TREATMENT OF POLYMYALGIA RHEUMATICA WITH TOCILIZUMAB: RESULTS OF AN OBSERVATIONAL RETROSPECTIVE MULTICENTER STUDY. ANNALS OF THE RHEUMATIC DISEASES. 80:662.

Pages